OR WAIT null SECS
- Advertise
- About Us
- Editorial Board
- Contact Us
- Job Board
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2021 MJH Life Sciences™ and Infection Control Today. All rights reserved.
ACIP Recommendations for Use of Seasonal Influenza Vaccines
The Aug. 7, 2015 issue of the CDC's Morbidity and Mortality Weekly Report (MMWR) provides a report that updates the 2014 recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding the use of seasonal influenza vaccines. Updated information for the 2015-16 season includes:
- Antigenic composition of U.S. seasonal influenza vaccines
- Information on influenza vaccine products expected to be available for the 2015-16 season
- An updated algorithm for determining the appropriate number of doses for children aged 6 months through 8 years
- Recommendations for the use of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) when either is available, including removal of the 2014-15 preferential recommendation for LAIV for healthy children aged 2 through 8 years.
To read further from the MMWR report, CLICK HERE.
Reference: Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR and Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season. MMWR. Aug. 7, 2015; 64(30);818-825